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Objectives. We postulated that preoperative assessment of both
regional wall motion and left ventricular ejection fraction would
serve as an accurate prognostic Indicator of long-term cardiac
mortally and functional outcome In patients treated with an
Implantable cardioverter-dellbrillator.
Background. Long-term cardiac mortality has remained high
in patients receiving an implantable cardioverter-defibrillator .
The ability to risk stratify patients before defibrillator implanta-
tion Is becoming increasingly Important from a medical and
economic standpoint.
Methods, The hypothesis was retrospectively tested in 74
patients who had received an Implantable eardtoverter-
defbrillator. Left ventricular ejection fraction and regional wall
atotioo score, derived from centerline chord motion analysis, were
calculated for each patient from the preoperative right anterior
oblique contrast ventriculogram . Wall motion store was the only
significant Independent predictor of long-term cardiac mortality
and ftnctional status by i;4mltivariate analysis because of Its
enhanced prognostic capability in patients with an ejection frac-
tion in the critical range d30% to 40% .
Since its introduction by Mirowski et al . (1) in 1980, the
implantable ;ardioverter-defibrillator has become accepted
as an effective therapy for preventing sudden death in
patients with malignant ventricular arrhythmia . Despite a
low incidence of sudden death (2,3), long-term cardiac
mortality has remained relatively high after implantation of
the device (2,4-9) . The majority of nonsudden cardiac
deaths have been attributed to progressive heart failure
(2,4-9) . Although major series have reported sudden death
and total cardiac mortality rates, a significant limitation of
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Results. Patients with an ejection traction >40% had S,3-year
cardiac mortality rate of 0% compared with 25% for those with
an ejection fraction of 30% to 40% and 48% for those with an
ejection fraction <30% (p < 0.05). Similarly, 75% of patients
with an ejection fraction >40% were In New York Heart Associ-
ation functional class I or II during long-term follow-up compared
with 59% of those with an ejection fraction 30% to 40% and 29%
of those with an ejection fraction <30%. Among patients with an
ejection fraction of 30% to 40%, those with a wall motion score
>16% had a 3-year cardiac mortality rate of 0% compared with
71% of those with a wall motion score :516% (p = 0.002). In
addition, 86% of patients with a wall motion score >16% were In
functional class I or II during long-term follow-up compared with
13% of those with a wall motion score X16% (p = 0 .001).
Conclusions . Long-term cardiac mortality and functional out-
come in patients receiving an Implantable cardioverter •
defibrillator can be predicted if the left ventricular ejection
fraction and regional wall motion score are measured preopera-
tively .
(J Am Cog Cry 1993 ;22 .1093--9)
these reports is that the late functional status of patients after
defibrillator implantation has not been well characterized .
Both long-term cardiac mortality and functional outcome
are important criteria by which to evaluate the overall
benefit of implantable cardioverter-defibrillator therapy . For
this reason, the ability to risk stratify patients before they
receive the device into groups predicted to have a favorable
or unfavorable outcome is becoming increasingly important
from both a medical and economic standpoint (10). Several
previous studies (8,11-17) have analyzed the effects of left
ventricular ejection fraction on long-term cardiac mortality
after defibrillator implantation . We (18) have reported that a
preoperative wall motion score derived using centerline
chord motion analysis is an independent predictor of long-
term survival and functional outcome after aneurysmectomy
and subendocardial resection for ventricular tachycardia. In
that study, we demonstrated that a wall motion score !g l6%a
or >16% stratified patients into a high and a low risk group,
respectively . We therefore postulated that a preoperative
assessment of wall motion score in addition to measurement
of ejection fraction would serve as an accurate prognostic
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indicator of both long-term cardiac mortality and functional
outcome in patients who underwent defibrillator implanta-
tion. This hypothesis was retrospectively tested in a group of
74 patients who had undergone implantable cardioverter-
defibrillator implantation at our institution .
Methods
Between June 1986 and July 1991, 85 patients received an
implantable cardioverter-defibrillator at our institution .
Eleven patients whose preoperative contrast left ventriculo-
C
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grams were technically inadequate for the analysis described
in the study are excluded from this report. The clinical
characteristics of the remaining 74 patients who comprised
the study group are shown in Table 1 .
Preoperative evaluation. All patients underwent preoper-
ative contrast ventriculography and selective coronary an-
giography using standard techniques. A critically stenosed
coronary artery was defined as a50% visual cross-sectional
narrowing of the blood vessel in any angiographic view .
> ndocardial contours were traced from the preoperative
right anterior oblique ventriculogram in end-systole and
end-diastole. Global left ventricular ejection fraction was
calculated as described by Sandier and Dodge (19) and
Kennedy et al . (20) iTrnnity Computing Systems) . Centerline
chord motion analysis, as described by Sheehan et al . (21),
was used to assess quantitatively regional left ventricular
function (Trinity Computing Systems) (Fig . 1) . In this tech-
nique, endocardial motion is measured along 100 chords
constructed perpendicular to a centerline drawn midway
between the end-diastolic and end-systolic contours in the
right anterior oblique projection. The last 20 chords are not
analyzed because they primarily reflect motion of the mitral
valve. The motion of each chord is then normalized for heart
size by dividing by the length of the end-diastolic circumfer-
ence. This value is then converted into units of standard
deviation (SD) from the normal mean motion of each chord
as derived from a normal reference population. Normal
motion is considered to be between I and -I SD from
reference . Hypokinetic motion is defined as less than -l cD
and hyperkinetic motion as >1 SD from reference . In this
study, wall motion score was defined as the number of
chords displaying normal or hyperkinetic motion expressed
as a percent of the 80 chords analyzed .
Surgical techniques. A left anterior thoracotomy ap-
proach was used in all patients who underwent defibrillator
implantation alone. In the 26 patients who required concom-
Figure 1 . Centerline method of regional wall motion
analysis. These data are from a normal patient studied
in our catheterization laboratory . A, The centerline (L)
is constructed midway between the end-diastolic and
end-systolic left ventricular contours in the right ante-
rior oblique projection. Motion is measured along 100
chords constructed perpendicular to the centerline .
Chords 81 to 100 are not analyzed because they
primarily reflect motion of the mitral valve. B, The
motion of each chord is normalized by the end-
diastolic circumference to yield a fractional shortening
(FS) . The fractional shortening of each chord is plotted
along with the normal mean fractional shortening of
each chord and I SD above and below this mean. C,
The fractional shortening of each chord is plotted in
units of SD from the normal mean motion .
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Table 1
. Clinical Characteristics of 74 Study Patients
Age (yr)
60 ± 12
Male
64(86)
Female
10(14)
Presenting arrhythmia
Sustained monomorphic ventricular tachycardia 42(57)
Cardiac arrest
20(27)
Syncope (sustained monomorphic ventricular 12(16)
tachycardia at electrophysiolagic study)
Structural heart disease
Coronary artery disease 53(72)
Dilated cardiomyopathy 13(18)
Other (valvular, hypenrophic ca . diomyopathy, no 800)
structural heart disease)
Inducible arrhythmia at baseline ele :traphysiologic study
Sustained monomorphic ventricular tachycardia 5605)
Polymorphic ventricular tachycardialvcntricular 902.5)
fibrillation
Noninducible 90215)
Left
ventricular ejection fraction (%) 35{14
Wall motion score 1%) 24 ± 22
Concomitant therapy
Amiotiarone 43(58 ,
Type IA antiarrhythmic drugs 10 (14'+
Coronary artery bypass grafting 26 (351
Hospital deaths 20)
itant coronary artery bypass grafting, a median sternotomy
approach was used . An epicardial patch-patch configuration
was used in all patients . The implantable cardioverter-
defibrillator models used were models 1400, 1420, 1500,
1520, 1550 and 1600 (Cardiac Pacemakers, Inc .) . All patients
had an intraoperative defibrillation threshold X20 J . Defibril-
lation efficacy was retested before hospital discharge .
Long-term follow-up. Long-term follow-up was obtained
in all 72 patients discharged from the hospital . Data concern-
ing mortality and New York Heart Association functional
class were obtained by direct or telephone contact with the
patient, the patient's family members or the patient's local
physician. Each patient was assigned a functional class at 6
and 24 months after hospital discharge . Cause of death was
classified as either cardiac or noncardiac . Cardiac mortality
was further divided into nonarrhythmic death (usually con-
gestive heart failure) or sudden death (including arrhythmias
associated with acute myocardial infarction) on the basis of
criteria proposed by the Cardiac Arrhythmia Pilot Study
investigators (22) .
Statistical analysis. Data were compiled into a computer-
ized data bank (RSI, BBN Software Products Corp .) and
analyzed using BMDP (BMDP Statistical Software) . Clinical
variables (gender, age, type of structural heart disease,
presenting ;arrhythmia, concomitant amiodarone use, con-
comitant tyke IA antiarrhythmic drug use and concomitant
coronary artery bypass grafting) ; electrophysiologic vari-
ables (inducibility of ventricular tachycardia at electrophys-
iologic study) ; and angiographic variables (left ventricular
ejection fraction, wall motion scare and the number of
critically stenosed coronary arteries) were compared using a
Cox regression analysis . In this model, variables are ex-
cluded in stepwise fashion whenever the p value for a
significant association is >0 .1 . The Cox regression analyses
and Kaplan-Meier survival curves were calculated using two
'Patients who underwent urgent heart transplantatior, were classified in the group with
cc
a
.diac.relaied death in
1,u•. ;inalysis . LVEF
a
left ventricular ejection fraction ; NS = p '
0.05 .
methods. In the first method, the three patients who under-
went urgent heart transplantation for heart failure or shock
were counted as having had a cardiac nonarrhythmic death
(Table 2). In the second method, these patients were cen-
sored from further mortality analysis at the time of trans-
plantation. Data from both analyses are described in the
following sections. Survival curves were compared using the
Breslow test. Subgroup comparisons were made using the
chi-square or Fisher exact test where appropriate . Statistical
significance was defined as p < 0 .05. All continuous vari-
ables were expressed as mean value ± SD .
Results
The mean ejection fraction for the entire study population
was 35 ± 14%, and the mean wall motion score was 24 ±
22%. There was good linear correlation between wall motion
score and ejection fraction for the entire study group (r
0.85) (Fig . 2) . Ejection fractions >40% were associated with
a high wall motion score (> 16%), and ejection fractions
<30% were associated with a poor wall motion score
(_<l6%). However, in the 27 patients with an ejection frac-
tion between 30% and 40%, there was often disparity be-
tween wall motion score and ejection fraction, with a poor
linear correlation coefficient (r = 0 .17) .
Hospital mortality. Severity-two patients (97%) were dis-
charged from the hospital. The two in-hospital deaths were
due to intractable heart failure (one patient) and to respira-
tory failure secondary to amiodarone-induced pulmonary
toxicity (one patient).
Cardiac mortality. During a mean follow-up of 21 *_ 13
months,, there were 13 cardiac-related deaths (including
in-hospital mortality) and 4 noncandiac-related deaths . An
additional three patients underwent ingcnt heart transplan-
tation because of intractable heart failure or incessant ven-
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"able 2
. Univari%te and Multivariate Analyses for Cardiac Mortality*
Patients With LVEF 30% to
All Patients (p value)
40% (p value)
Univariatc Multivariate
Univariate
Multivariate
Analysis
Analysis Analysis
Analysis
Gender
NS NS
NS NS
Age
NS NS
NS NS
Underlying heart
disease NS
NS qS
NS
Presenting arrhythmia
NS
NS ±IS
NS
Inducibility of ventricular tachycardia
0.03 N.S
NS NS
at clectrophysiologic study
LVEF
< 0 .001 NS
NS NS
Wall motion score < 0
.0001 < 0.0101 < 0 .01
< 0.01
No. of diseased coronary arteries
NS
NS NS
NS
('50% diameter narrowing)
Coronary artery bypass grafting
NS NS NS
NS
Am odarone use NS
NS NS NS
Tvre IA antiarrhythmic drug use NS NS
NS NS
t096
	
MATH ET AL .
RISK STRATIFICATION OF PATIENTS RECEIVING AN ICD
0
1.00
0.00
0.60-
0.441
0. =0
10
-~
l4i~l1
w -3sx
- -	
0 ~•
~ S 00
0
so t0 8o20 30 40 80
LVEF (%)
Figure 2 . Relation between wall motion score (WMS) and left
ventricular ejection fraction (LVEF) . In patients with an ejection
fraction in the range 30% to 40%, cardiac mortality or urgent heart
transplantation was confined to those patients with a wall motion
score 916% .
tricular arrhythmia, or both . Heart failure (nine patients) was
the most common mode of death. There were only two
sudden deaths during long-term follow-up . Inducibility of
ventricular tachycardia at electrophysiologic study (p <
0.0S), left ventricular ejection fraction (p < 0 .001) and wall
motion score (p < 0.0001) were all significant univariate
predictors of cardiac mortality if patients who underwent
heart transplantation were classified as having had a cardiac-
related death . However, if these three patients were cen-
sored from further analysis at the time of transplantation, left
ventricular ejection fraction (p < 0.001) and wall motion
score (p < 0.001) were the only significant univariate pre-
Figure 3. Survival free of cardiac death or urgent transplantation . A,
Patients are stratified by ejection fraction (EF). Patients with an
ejection fraction >40% had a significantly better long-term survival
than that of patients with an ejection fraction in the range 30% to
4096 or <30% (p < 0.05), R, Patients with an ejection fraction
between 30% and 40% are stratified by a wall motion score (WMS)
>16% or 916% . Patients with a wall motion score >116% had a
significantly better long-term survival than that of patients with a
wall motion score 916% (p = 0.002). Post-implant = after implan-
tation.
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dictors of cardiac mortality. By Cox regression analysis,
wall motion score was the only significant independent
predictor of cardiac mortality (p < 0 .001), whether patients
with heart transplantation were classified as having had a
cardiac-related death or were censored from the mortality
analysis at the time of transplantation.
Life-table analysis for cardiac mortality is illustrated in
Figure 3A. Patients with an ejection fraction >40% had a
significantly better long-term survival than that of patients
with an ejection fraction 940% (p < 0 .05). There were no
cardiac-related deaths among the 20 patients in the former
group during a mean follow-up period of 29 ± 14 months. All
patients with an ejection fraction >40% had a wall motion
score > 160 .
There were four cardiac-related deaths and two urgent
cardiac transplantations among the 27 patients with an
ejection fraction of 30% to 40% during a mean follow-up
period of 22 ± 12 months . In this cohort, wall motion score
was the only significant predictor of cardiac mortality (in-
cluding or excluding the two transplant recipients as patients
who died) (Table 2) . A wall motion score SIM or >16%
was effective In stratifying patients into a high or a low risk
group, respectively (Fig. 3B). The 10 patients in this group
who had a wall motion score
:s16%
had a 3-year cardiac
mortality rate of 71%, compared with a 0% cardiac mortality
rate among the 17 patients with a wall motion score >16%
(p = 0.002) .
There were nine cardiac-related deaths and one urgent
cardiac transplantation among the 27 patients with a left
ventricular ejection fraction <30% during a mean follow-up
period of 15 ± 1 I months . Wall motion score was not helpful
in risk stratifying patients in this group because all but one
patient had a wall motion score s16% .
Functional status. Among the 72 patients discharged from
the hospital . 74% were in functional class I or II at 6 months
and 54% were in class I or II at 24 months after hospital
discharge. Left ventricular ejection fraction and wall motion
score were both univariate predictors of long-term functional
class. However, after multivariate analysis, wall motion
score was the only significant independent predictor of
L~~ d∎1T)
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functional status at 6 months (p < 0 .01) and 24 months (p <
0.001) after device implantation .
Patients with an ejection fraction >40% were more likely
to be in functional class I or 11 during long-term follow-up
than were patients with an ejection fraction X40% (Fig . 4A) .
At 6 months, 90% of the 20 patients in this group were in
functional class I or 11, and at 24 months 75% were in class
I or 11 . Wall motion score was not helpful in predicting
functional outcome in this patient group because all patients
had a wall motion score >16%.
At 6 months, 85% of the 27 patients with an ejection
fraction between 30% and 40% were in functional class I or
11, and at 24 months 59% in were class I or II (p - NS vs .
patients with an ejection fraction >40%) . Patients in this
group with a wall motion score >16% were more likely than
patients with a score {l6% to be in class l or 11 at 6 trontl,s
(94% vs. 70%, respectively, p = NS) and at 24 months (86%
vs. 13%, respectively, p = 0 .001) after defibrillator implan-
tation (Fig. 4B) .
At 6 months, 52% of the 27 patients with an ejection
fraction <30% were in functional class a or II, and at 24
months only 29% were in class I or 11 . All but one of the wall
motion scores in this group were s16% and were therefore
not helpful i, predicting functional outcome .
DiSCUSSiolr
Our data indicate that by assessing preoperative regional
wall motion using a reproducible quantitative technique in
addition to measuring left ventricular ejection fraction, the
long-term cardiac mortality and functional outcome of pa-
tients treated with an implantable cardioverter-defibrillator
can be predicted with reasonable accuracy. Patients with an
initial ejection fraction >40% had a good wall motion score
and an excellent long-term survival and functional outcome .
In contrast, patients with an ejection fraction <30% and a
poor wall motion score had a significantly higher cardiac
mortality rate and poorer long-term functional outcome .
Wall motion score was most helpful in patients in an inter-
mediate group with an ejection fraction between 30% and
40%. This cohort, which included 27 (36%) of 74 of our study
patients, could be further stratified into high and low risk
WFA40%
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Figure 4
. Functional class of patients at 6 and 2
.1 months after
receipt of an implantable cardioverter-defibrillator
. A, Patients are
stratified by ejection fraction (EF)
. Patients with an ejection fraction
>40% were more likely to be in New York Heart Association
functional class I or 11(1 or 2) during long-term follow-up than were
patients with an ejection fraction between 30% and 40% or <30
. B,
Patients with an ejection fraction between 30% and 40% are strati-
fied by a wall motion score (WMS) > 16% or s16%
. Patients with a
wall motion score > 16% were significantly more likely to be in
functional class I or 11 during long-term follow-up than were patients
with a wall motion score 516% (p = 0.001 at 24 months)
.
groups by a quantitative measurement of regional wall
motion . In this group, patients with a wall motion score
:5160/c had a 3-year cardiac mortality rate of 71% . and an
additional 25% had symptomatic heart failure within 2 years
of implantation . In contrast, no patient in this group with a
wall motion score >16% had a cardiac-related death, and
only 7% had symptomatic heart failure within the same time
interval .
Previous studies . Previous studies (8,11-17) have re-
ported the prognostic importance of preoperative left ven-
tricular ejection fraction on subsequent survival after defi-
brillator implantation. Patients with an ejection fraction
a30% have been shown to have a significantly better long-
term survival rate than that of patients with an ejection
fraction <30% (8,13,15-17) . Akhtar et al . (16) reported a
3-year total mortality rate of 22% in 96 patients with an
ejection fraction of 30% to 40% receiving an implantable
cardioverter-defibrillator. However, most other studies
(8,13-15,17) have not included a separate analysis of patients
with an ejection fraction in this range .
The reported 3-year survival rates for patients with an
ejection fraction <30% have ranged from 57% to 81%
(8,12-17). Axtell et al . (12) observed a 3-year survival rate of
81% in 68 patients with an ejection fraction <30% . However,
79% of their patients were in functional class I or it before
surgery, 21% were in class IIl, and no patient was in class
IV. Other series (8,13) that have included a higher pet cent of
patients who were in functional class III or IV have reported
lower long-term cardiac survival rates in patients with an
ejection fractions <30% .
Although functional class in a patient in stable condition
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can effectively predict prognosis, it may be difficult to assess
functional class in patients in the early recovery period after
a recent myocardial infarction or cardiac arrest with its
associated complications, a scenario common in implantable
cardioverter-defibrillator recipients. This study demon-
strates that by quantitatively measuring preoperative re-
gional wall motion in addition to ejection fraction, an objec-
tive assessment of long-term mortality risk and functional
outcome can be obtained before defibrillator implantation .
Cereal Implications . The long-term cardiac mortality
and functional outcome of patients treated with an i, aplant-
able cardioverter-defibrillator can be predicted with reason-
able accuracy by measuring both ejection fraction and
regional wall motion . Patients with an ejection fraction
>40% or in the range 30% to 40% associated with a wall
motion score > 1696 have an excellent long-term survival and
functional outcome after implantable cardioverter-defibrilla-
tor implantation, In contrast, patients with an ejection frac-
tion <30% or of 30% to 40% and a wall motion score s 16%
remain at high risk for cardiac mortality and the develop.
ment of symptomatic heart failure during long-term follow-
up. In this high risk group of patients, the same degree of
long-term benefit from implantable cardioverter-defibrillator
implantation should not be anticipated . Although sudden
death may be prevented, death of nonarrhythmic origin or a
reduced quality of life due to heart failure frequently occurs .
Assessment of both ejection fraction and regional wall
motion may allow better medical and economic utilization of
the implantable cardiover tr-defibrillator, High risk patients
may be referred earlier for heart transplantation or treated
initially with the best available pharmacologic therapy be-
cause there is limited long-term benefit from the implantable
cardioverter-defibrillator in this group of patients . However,
a randomized study of implantable cardioverter-defibrillator
therapy versus pharmacologic therapy has not been reported
to date, Patients who improve clinically and whose condition
remains stable with
Medical therapy may later be considered
candidates for implantable cardioverter-defibrillator as an
adjunct or alternative to antic rrhythmic drug treatment . The
implantable ca rdioverter-defibrillator may conceivably be
used as a "bridge to transplantation" in this high risk group ;
however, even this use may be of limited benefit owing to the
different mechanisms responsible for sudden deat in these
patients (23).
Lkaifatloas of Study. There was some inevitable :.election
bias during the period of the study. Patients with air ejection
fraction <20% and ventricular arrhythmias were usually not
considered candidates for receipt of an implantable cardio.
vetter-defibrillator unless they had a reasonable functional
status
. Patients with both a low ejection fraction and a poor
baseline functional status were usually referred for heart
transplantation, or a decision was made to treat them con-
servatively with only the best available pharmacologic ther-
apy. This clinical practice may have resulted in a better
long-term outcome in the patients with the lowest ejection
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October 1993:1093-9
fractions (i .e., <30%) than if all such patients had received
an implantable cardioverter-defibrillator.
Three of the 16 patients classified as having a cardiac-
related death in the study were heart transplant recipients.
We believe that we are justified in classifying these patients
in the group with cardiac death because each was hospital-
ized in an intensive care unit with either intractable heart
failure or incessant ventricular arrhythmias and was antici-
pated to have had a very limited survival without transplan-
tation. However, when they are censored at the time of
transplantation, the same general conclusions about the
value of wall motion score still apply .
Our data can be strictly applied only to second-generation
implantable cardioverter-defibrillators . Newer, more capa-
ble implantable cardioverter-defibrillators are now undergo .
ins clinical trials (24) . These devices may require less
invasive implantation procedures, may require less concom-
itant antiarrhythmic drug therapy and may convert many
arrhythmias by antitachycardia pacing, rather than by
shocks. Although not yet clinically proved, these advantages
might lead to reductions in total mortality and Improvement
in functional outcome after implantation .
There are radionuclide and echocardiographic techniques
that may be used for regional wall motion analysis . It may be
possible to adapt the methods used for contrast ventriculo-
gram analysis to these techniques and thus achieve the same
prognostic information using a noninvasive approach .
Finally, this was a retrospective study in a relatively
small number of patients. However, measurement of a wall
motion score is relatively simple, and our observations could
be confirmed both retrospectively and prospectively by
other centers .
Conclusions. Long-term cardiac mortality and functional
outcome in patients receiving an implantable cardiavertcr
defibrillator for sustained ventricular tachycardia or ventric-
ular fibrillation can be effectively predicted if the left ven-
tricular ejection fraction and regional wall motion score are
measured preoperatively . Assessment of both of these fac-
tors may allow better medical and economic utilization of
these expensive but potentially lifesaving devices .
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